Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • KP Group’s Faruk Patel: Championing a better environment for future generations Press Release
  • EDUCATING THE MARKET Initiative by Yield 4 Finance (Y4F) Business
  • How G.D. Goenka International School Surat is Shaping Future-Ready Learners Through Innovation, Leadership and Well-being Education
  • Gautam Khaitan pays tribute to the vanguard of modern India English
  • Randeep Singh Triumphs in Four International Badminton Tournaments! Sports
  • Powering Simhastha 2028: Magellanic Cloud’s Provigil Wins ₹12.13 Crore Western Railway Deal Business
  • UniHealth Launches Comprehensive Eye Care and Ophthalmology Services at UMC Victoria Hospital, Uganda Business
  • Breaking Barriers & Chasing Dreams : Melissa Menezes Crowned 1st Runner-Up in Elite Category at Mrs. India – Empress of The Nation 2025 Lifestyle

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • World Heart Day 2025: Rising Heart Disease in the Young – Why Waiting Is Dangerous Health
  • Meet 10 Leaders who make India a Global Bright Spot Health
  • Partha Dental Makes Invisalign and Partha Aligners More Affordable Than Ever Health
  • Hope for Parenthood: Insights from Leading IVF and Gynaecology Experts on this Doctor’s Day Health
  • Madhavbaug to conduct ‘Vishwaveda’ to highlight Ayurveda’s unique strength Health
  • Dr Batra’s® Healthcare Introduces World’s Most Advanced Treatment for Targeted Hereditary Hair Loss: XOGEN Health

Recent Posts

  • Visa For Nation: Empowering Global Dreams Through Trusted Immigration Expertise and Proven Client Success
  • Q&T Foods Limited’s IPO Opens from August 12, 2026 to August 14, 2026; Issue Price Fixed at Rs. 115 Per Equity Share
  • Second edition of ‘Homeopathy for Anemia’ released in New Delhi
  • Ministry of Agriculture, Food and Rural Affairs and aT Host “2026 K-Food Fair in New Delhi, India”
  • Fascinate Textiles Heads to NSE Emerge; ₹66.98 Crores IPO Opens August 11, 2026

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • BHAARTI: Pioneering the Future of Agriculture and Aerospace Initatives in India Education
  • CASE Group is Spearheading India’s Energy Sufficiency drive and is all set to create a paradigm shift in Balance of payments Business
  • Iyda Payments Partners with Federal Bank for Bill Payments Services Press Release
  • Glimpse up the world @worldwithmaria English
  • “Line of Control”, a powerful cinematic adaptation of internationally acclaimed novel The Collaborator Entertainment
  • Desi Tadka Music Present “Dam Ali” — A Soul-Stirring Qawwali Tribute To Hazrat Ali That Awakens the Spirit of Devotion Entertainment
  • Asian Granito India Ltd reports Consolidate Net Profit of Rs.91.8 crore, Cons. Net Sales of Rs.1563.8 crore in FY 22 Business
  • Tata Motors Finance Inks Strategic Partnership with CJ Darcl Logistics Ltd. to Offer INR 125 Cr. Limit for Diverse Financing Facilities Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme